Karyopharm Therapeutics Inc. (KPTI) — Dilution Risk Analysis

Current Snapshot

Karyopharm Therapeutics Inc. (KPTI) has a DilutionWatch score of 81/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
22,681,460 Source
Public Float
14,695,532 Source
Float as % of Outstanding
64.8%

Dilution Risk Score

Score: 81/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 8-K 1, 4 8.

FormFiledAccession
xbrl 2026-06-30 xbrl-5045-xbrl_warrant
8-K 2026-03-24 0001193125-26-120770
4 2026-03-03 0001942597-26-000003
4 2026-03-03 0001825322-26-000003
4 2026-03-03 0001865796-26-000003
4 2026-03-03 0001837741-26-000003
4 2026-03-03 0002045943-26-000003
4 2026-02-19 0001193125-26-059332
4 2026-02-09 0001193125-26-042799
4 2026-02-04 0001193125-26-037584

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 14 months Source
Three-year share count growth 9999.0% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 81/10) Source
Cash Runway
14 months Source
Share Count Growth (3-Year)
9999.0% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.